Informed Consent
Investigators are reminded that information given to the subject
or the representative shall be in language understandable to the
subject or the representative. Informed consent shall be documented
by the use of a written consent form approved by the IRB and signed
by the subject or the subject's legally authorized representative,
as well as a witness. A copy shall be given to the person signing
the form. The basic elements of a consent form include:
1. A statement that the study involves research, an explanation
of the purposes of the research and the expected duration of the
subject's participation, a description of the procedures to be
followed, and identification of any procedures which are experimental;
2. A description of any reasonably foreseeable risks or discomforts
to the subject;
3. A description of any benefits to the subject or to others
which may reasonably be expected from the research;
4. A disclosure of appropriate alternative procedures or courses
of treatment, if any, that might be advantageous to the subject;
5. A statement describing the extent, if any, to which confidentiality
of records identifying the subject will be maintained;
6. For research involving more than minimal risk, an explanation
as to whether any compensation and an explanation as to whether
any medical treatments are available if injury occurs and, if
so, what they consist of, or where further information may be
obtained;
7. Persons to contact for answers to pertinent questions about
the research and research subjects' rights, and whom to contact
in the event of a research related injury to the subject. The
consent document should provide the name of a specific person
and the telephone number to contact for answers to questions about:
1) the research subjects' rights; 2) a research related injury;
and 3) the research study itself. It is as important for the subject
to know why an individual should be contacted as it is for the
subject to know whom to contact. The person(s) named for questions
about research subjects' rights should NOT be the primary investigator
(as this may tend to inhibit subjects from reporting concerns
and discovering possible problems). If a student is conducting
the research, please include the faculty member who is mentoring
the research project as the contact person to answer questions
#2 and #3 above. Please also include the IRB
Chairperson to answer question #1 above.
8. A statement that participation is voluntary, refusal to participate
will involve no penalty or loss of benefits to which the subject
is otherwise entitled, and the subject may discontinue participation
at any time without penalty or loss of benefits to which the subject
is otherwise entitled.
Additional Elements of Consent Form
When applicable, one or more of the following elements of information
shall also be provided to each subject:
1. A statement that the particular treatment or procedure may
involve risks to the subject (or to the embryo or fetus, if the
subject is or may become pregnant) which are currently unforeseeable;
2. Anticipated circumstances under which the subject's participation
may be terminated by the investigator without regard to the subject's
consent;
3. Any additional costs to the subject that may result from
participation in the research;
4. The consequences of a subject's decision to withdraw from
the research and procedures for orderly termination of participation
by the subject;
5. A statement that significant new findings developed during
the course of the research which may relate to the subject's willingness
to continue participation will be provided to the subject; and
6. The approximate number of subjects involved in the study.
|